Barinthus Biotherapeutics plc

BRNSNASDAQ Global Market·USD·Closed

BRNSNASDAQ·USD·Closed

$0.56

+0.14%

$0.56

+$0.00 (0.14%)

52W Range

3thpctl

Volume

0.16×avg

Mkt Cap

22.79MUSD

P/E

-0.4TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

3thpctl

Volume

0.16×avg

Market Cap

22.79MUSD

P/E Ratio

-0.4TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-100.0% / yr

Operating margin0.0%

ROIC-68.7%

Financially safe

Stretched

Debt / equity0.17×

Interest coverage-1116.7×

Current ratio6.05×